We are live on ! Find out more
INDV icon

Indivior Pharmaceuticals
INDV

259 hedge funds and large institutions have $4.36B invested in Indivior Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 90 funds opening new positions, 84 increasing their positions, 67 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,820% more call options, than puts

Call options by funds: $78M | Put options by funds: $4.07M

246% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 26

63% more capital invested

Capital invested by funds: $2.68B → $4.36B (+$1.68B)

31% more funds holding

Funds holding: 198 → 259 (+61)

25% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 67

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

Holders
259
Holders Change
+61
Holders Change %
+30.81%
% of All Funds
3.15%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
90
Increased
84
Reduced
67
Closed
26
Calls
$78M
Puts
$4.07M
Net Calls
+$74M
Net Calls Change
+$18.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$290M
2
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$97.8M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$70.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$61.3M
5
State Street
State Street
Massachusetts
+$56.3M

Top Sellers

1
OCM
Oaktree Capital Management
California
-$7.65B
2
TSC
Two Seas Capital
New York
-$165M
3
DM
Deerfield Management
New York
-$110M
4
Goldman Sachs
Goldman Sachs
New York
-$104M
5
NM
Newtyn Management
New York
-$50.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSERS
101
Louisiana State Employees Retirement System
Louisiana
$2.05M +$1.75M +57,200 New
Mirae Asset Global ETFs Holdings
102
Mirae Asset Global ETFs Holdings
Hong Kong
$2.02M +$153 +5 +0%
State of New Jersey Common Pension Fund D
103
State of New Jersey Common Pension Fund D
New Jersey
$1.91M +$910K +29,810 +127%
Prudential Financial
104
Prudential Financial
New Jersey
$1.9M +$1.15M +37,510 +242%
CCIA
105
Campbell & Co Investment Adviser
Maryland
$1.9M -$27.7K -908 -2%
Wellington Management Group
106
Wellington Management Group
Massachusetts
$1.88M -$27.7K -908 -2%
State of Wisconsin Investment Board
107
State of Wisconsin Investment Board
Wisconsin
$1.83M -$134K -4,384 -8%
IIM
108
INTECH Investment Management
Florida
$1.83M +$298K +9,773 +24%
KK
109
KLP Kapitalforvaltning
Norway
$1.83M -$15.3K -500 -1%
Susquehanna International Group
110
Susquehanna International Group
Pennsylvania
$1.75M -$16.9M -553,378 -92%
Credit Agricole
111
Credit Agricole
France
$1.63M +$1.39M +45,558 New
VOYA Investment Management
112
VOYA Investment Management
Georgia
$1.62M +$700K +22,924 +103%
LPL Financial
113
LPL Financial
California
$1.6M +$1.36M +44,695 New
Blackstone Inc
114
Blackstone Inc
New York
$1.52M +$1.29M +42,288 New
RG
115
Rathbones Group
United Kingdom
$1.51M -$21.6K -706 -2%
OQS
116
Occudo Quantitative Strategies
Florida
$1.45M +$248K +8,129 +25%
EGM
117
Engineers Gate Manager
New York
$1.44M -$7.3K -239 -0.6%
New York State Common Retirement Fund
118
New York State Common Retirement Fund
New York
$1.38M – – –
Zurich Cantonal Bank
119
Zurich Cantonal Bank
Switzerland
$1.37M -$18K -591 -2%
ACM
120
Aquatic Capital Management
Illinois
$1.35M +$1.02M +33,373 +771%
OAC
121
OMERS Administration Corp
Ontario, Canada
$1.32M +$1.12M +36,797 New
SWM
122
Sandro Wealth Management
New Jersey
$1.31M +$1.12M +36,585 New
BCM
123
Bridgeway Capital Management
Texas
$1.31M +$1.11M +36,500 New
AB
124
Amalgamated Bank
New York
$1.3M +$978K +32,033 +773%
Manulife (Manufacturers Life Insurance)
125
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.3M -$312K -10,221 -22%
3 4
5
6 7

INDV Hedge Fund Activity: Q4 2025 in Review

259 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Indivior Pharmaceuticals (INDV) for Q4 2025, worth a combined $4.36B — up 63% from $2.68B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new INDV positions and 26 closed out — a net gain of 64 holders — while 84 added to existing stakes and 67 trimmed.

The largest buyer was BlackRock, adding an estimated $290M. The largest seller was Oaktree Capital Management, cutting an estimated $7.65B.

  • 259 institutional investors held Indivior Pharmaceuticals (INDV) as of Q4 2025, up from 198 in Q3 2025.
  • Funds reported $4.36B of Indivior Pharmaceuticals stock for Q4 2025, up 63% quarter-over-quarter.
  • 90 funds opened new Indivior Pharmaceuticals positions in Q4 2025 and 26 closed out, a net change of +64 holders.
  • The largest Indivior Pharmaceuticals buyer in Q4 2025 was BlackRock, an estimated $290M added.
  • The largest Indivior Pharmaceuticals seller in Q4 2025 was Oaktree Capital Management, an estimated $7.65B sold.

Based on aggregated 13F filings for Q4 2025.